Pelvic support tissue

Pelvic support tissue refers to the network of connective tissue, fascia, ligaments, and muscles that maintain the position and functional integrity of pelvic organs (bladder, uterus, rectum)[1][3][4][5]. It includes structures such as the endopelvic fascia, arcus tendineus, cardinal and uterosacral ligaments, and muscles of the pelvic floor (levator ani, coccygeus)[1][3][5]. The extracellular matrix is composed mainly of collagen (Types I and III), elastin, fibronectin, laminin, smooth muscle cells, and fibroblasts[2][4][6]. Biological functions center on maintaining pelvic organ support, ensuring continence, and facilitating childbirth[1][5]. Dysfunction or degradation of these tissues results in pelvic organ prolapse and related disorders[2][4][6]. The molecular mechanisms of disease (such as in POP) involve ECM remodeling, collagen degradation, imbalances in MMPs/TIMPs, and altered signaling pathways (e.g. TGF-β, HOXA11, RAGE), but these mechanisms are not specific to a discrete molecular target called "pelvic support tissue"[4][6]. In summary: "Pelvic support tissue" describes a group of connective and muscular tissues, not a molecule, receptor, or single therapeutic target. Requests involving drug interaction, molecular pathway, or biomarker specifics should instead focus on individual molecular components within these tissues (e.g., collagen, HOXA11, MMPs/TIMPs)[2][4][6].

Other names

Pelvic connective tissueEndopelvic fasciaPelvic floor support structuresPelvic floor connective tissuePelvic support structures